Tin tức & Cập nhật

Chỉ hiển thị Multimedia

12 risk factors linked to postoperative VTE in gynaecologic malignancy patients

03 Feb 2026

Several factors tend to increase the risk of venous thromboembolism (VTE) in patients with gynaecologic malignant tumours after surgery, reveals a study.

12 risk factors linked to postoperative VTE in gynaecologic malignancy patients

03 Feb 2026

NATALEE updates: Ribociclib benefit in HR+, ERBB– EBC sustained at 4 years

03 Feb 2026 bởi

In an updated analysis of the NATALEE* trial, the efficacy benefit of adjuvant ribociclib remains consistent even after the planned 3-year treatment duration for patients with HR+, ERBB2– early breast cancer (EBC).

NATALEE updates: Ribociclib benefit in HR+, ERBB– EBC sustained at 4 years

03 Feb 2026

Proton therapy tied to increased risk of osteoradionecrosis

02 Feb 2026 bởi

A study on patients with oropharyngeal squamous cell carcinoma (OPSCC) shows an association between proton therapy (PT) and a higher rate of osteoradionecrosis (ORN).

Proton therapy tied to increased risk of osteoradionecrosis

02 Feb 2026

Sesame oil helps avert phlebitis at IV cannula sites

30 Jan 2026 bởi

The use of topical sesame oil may prevent or reduce the severity of phlebitis at intravenous (IV) cannula sites in patients, suggests a Singapore study.

Sesame oil helps avert phlebitis at IV cannula sites

30 Jan 2026

Patient participation lacking in prostate cancer consultations

30 Jan 2026

A recent study has noted high variability in patient participation in consultations for clinically localized prostate cancer, with no consistent predictors. Moreover, time spent in expressing preferences, values, or the decision-making process is minimal.

Patient participation lacking in prostate cancer consultations

30 Jan 2026

Durvalumab plus FLOT improves survival in Asians with G/GEJ adenocarcinoma

30 Jan 2026 bởi

Adding durvalumab to 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) improves event-free survival (EFS) and overall survival (OS) in Asian patients with resectable gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, according to a subgroup analysis of the phase III MATTERHORN trial presented at ESMO Asia 2025.

Durvalumab plus FLOT improves survival in Asians with G/GEJ adenocarcinoma

30 Jan 2026

miRNA biomarkers may help personalize glioblastoma care

30 Jan 2026 bởi

A German study has found that overexpression of specific micro(mi)RNAs in native tumour tissue and primary glioblastoma (GBM) cell cultures are positively correlated with increased effectiveness of tumour-treating fields (TTFields) treatment, pointing to the potential of miRNAs as biomarkers in predicting treatment response to TTFields.

miRNA biomarkers may help personalize glioblastoma care

30 Jan 2026

Original New Drug Application Approvals by US FDA (1-15 January 2026)

30 Jan 2026

New drug applications approved by US FDA as of 1-15 January 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 January 2026)

30 Jan 2026

AI enhances diagnostic accuracy of mammograms

29 Jan 2026 bởi

A Singapore study shows that incorporating artificial intelligence (AI) into mammography can improve breast cancer detection rates.

AI enhances diagnostic accuracy of mammograms

29 Jan 2026

IBD with primary sclerosing cholangitis linked to increased risk of CRC

27 Jan 2026

Patients with inflammatory bowel disease (IBD) face an increased risk of colorectal cancer (CRC), and this association is especially pronounced for those who have primary sclerosing cholangitis (PSC), according to a study.

IBD with primary sclerosing cholangitis linked to increased risk of CRC

27 Jan 2026

Tin tức & Cập nhật

Xem bài viết Ung thư

Xem

Chuyên ngành:

12 risk factors linked to postoperative VTE in gynaecologic malignancy patients

12 risk factors linked to postoperative VTE in gynaecologic malignancy patients

NATALEE updates: Ribociclib benefit in HR+, ERBB– EBC sustained at 4 years

NATALEE updates: Ribociclib benefit in HR+, ERBB– EBC sustained at 4 years

Proton therapy tied to increased risk of osteoradionecrosis

Proton therapy tied to increased risk of osteoradionecrosis

Sesame oil helps avert phlebitis at IV cannula sites

Sesame oil helps avert phlebitis at IV cannula sites

Patient participation lacking in prostate cancer consultations

Patient participation lacking in prostate cancer consultations

Durvalumab plus FLOT improves survival in Asians with G/GEJ adenocarcinoma

Durvalumab plus FLOT improves survival in Asians with G/GEJ adenocarcinoma

miRNA biomarkers may help personalize glioblastoma care

miRNA biomarkers may help personalize glioblastoma care

Original New Drug Application Approvals by US FDA (1-15 January 2026)

Original New Drug Application Approvals by US FDA (1-15 January 2026)

AI enhances diagnostic accuracy of mammograms

AI enhances diagnostic accuracy of mammograms

IBD with primary sclerosing cholangitis linked to increased risk of CRC

IBD with primary sclerosing cholangitis linked to increased risk of CRC